JP Morgan Chase’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-100
Closed -$1.96K 7779
2026
Q1
$1.96K Hold
100
﹤0.01% 7018
2025
Q4
$2.84K Buy
+100
New +$2.71K ﹤0.01% 6889
2023
Q2
Sell
-133
Closed -$6.72K 6971
2023
Q1
$6.72K Hold
133
﹤0.01% 6201
2022
Q4
$8K Buy
+133
New +$10.3K ﹤0.01% 6071

Other funds holding CNBS

JP Morgan Chase's CNBS Position: Q2 2026 in Review

JP Morgan Chase sold out of Amplify Seymour Cannabis ETF (CNBS) in Q2 2026, closing a stake of 100 shares — an estimated $1.96K sold.

JP Morgan Chase first reported a position in CNBS in Q4 2022 and held it in 4 quarters. The position peaked at $8K in Q4 2022. 16 funds tracked by Wall St. Rank hold CNBS as of Q2 2026.

  • JP Morgan Chase reported no remaining Amplify Seymour Cannabis ETF position as of Q2 2026 after selling out during the quarter.
  • JP Morgan Chase sold 100 Amplify Seymour Cannabis ETF shares in Q2 2026, an estimated $1.96K.
  • JP Morgan Chase first reported a position in Amplify Seymour Cannabis ETF in Q4 2022 and held it in 4 quarters.
  • JP Morgan Chase's Amplify Seymour Cannabis ETF position peaked at $8K in Q4 2022.
  • 16 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.